RxDoctor Payments Data

Amy O Daniel

Family · Tupelo, MSNPI 1669879003

Payments from drug & device makers

$328in general payments, 2019–2025

Across 23 payments — averaging $14.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$96
  • Novo Nordisk$51
  • GSK$42
  • Boehringer Ingelheim$34
  • Shield Therapeutics Inc$30
  • Amgen$26
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$328100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$328 in reported general payments places this provider in the 45th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$59,827
Medicare patients
162
Services billed
2,009

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$62,498
MounjaroTirzepatide51$62,338
FarxigaDapagliflozin Propanediol59$55,462
TrulicityDulaglutide21$38,405
JardianceEmpagliflozin16$21,494
EliquisApixaban25$19,560
CholestyramineCholestyramine (With Sugar)13$1,703
Gabapentin116$1,635
Rosuvastatin Calcium127$1,330
Omeprazole117$1,311
Duloxetine Hcl59$1,207
Memantine Hcl33$1,162
Levothyroxine Sodium162$1,125
Ventolin HfaAlbuterol Sulfate18$1,085
Atorvastatin Calcium166$1,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$14$100,74372 claims
Novo NordiskOzempic$51$62,49844 claims
Boehringer IngelheimJardiance$34$21,49416 claims
AbbVieSynthroid$96$90914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,007 family providers in Mississippi.

Other family in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →